Raymond James raises Oscar Health price target to $42
Raymond James maintained Oscar Health at an Outperform rating and raised its price target to $42 from $34, per Benzinga ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.